Psychiatry was once big business for pharma, with drugs like Prozac making billions. Now a few breakthroughs are reviving ...

ECIM 2025 saw a heated discussion on whether anticoagulation in DVT should be treated like a chronic condition, as new ...

"Billionaire" and "successful hedge fund manager" are titles that carry significant weight on Wall Street. These and others ...

AbbVie Inc. enters the obesity market with GUBamy, a promising amylin analog. Click here to find out why ABBV stock is a Buy.

Viking Therapeutics eyes billion-dollar obesity drug markets with pivotal trials and major production deals. Read more about ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

The Maryland Senate voted to allow a state board to extend its mandate for lowering prescription drug costs to all residents.

In the latest chapter of the rapidly escalating trade war, Trump on Thursday threatened to impose a 200% tariff on wine, ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

But as the drugstore chain (WBA) prepares to go private and its rival CVS Health Inc. (CVS) experiments with smaller stores, some analysts and researchers see a possible future with even fewer ...